Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hotta

Showing results (121-130 of 169) with videos related to

Pageof 17
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1997
Role of a sialyl Lewis(x)-like epitope selectively expressed on vascular endothelial cells in local skin inflammation of the ratT Akahori, Y Yuzawa, K Nishikawa, et al.
Diabetologia|March 1, 1985
Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated ratsN Hotta, H Kakuta, H Fukasawa, et al.
Clinical Chemistry|June 1, 1994
Enzyme immunoassay for erythrocyte aldose reductaseC Nishimura, Y Hamada, T Tachikawa, et al.
Diabetes Care|October 7, 2000
Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patientsY Hamada, J Nakamura, K Naruse, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1993
A placebo-controlled double-blind study of epalrestat (ONO-2235) in patients with diabetic neuropathyY Goto, N Hotta, Y Shigeta, et al.
Journal of the Autonomic Nervous System|August 29, 1998
Centrally administered TRH-induced insulin secretion is impaired in the Otsuka-Long-Evans-Tokushima Fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitusY Chen, K Uemura, S Yoshioka, et al.
Neuroendocrinology|August 1, 1997
NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, affects the central nervous system to produce peripheral hyperglycemia in conscious ratsK Uemura, T Tamagawa, Y Chen, et al.
Experimental Physiology|November 1, 1995
Effect of an aldose reductase inhibitor, SNK-860, on deficits in the electroretinogram of diabetic ratsN Hotta, N Koh, F Sakakibara, et al.
Life Sciences|January 1, 1997
Diabetic neuropathy in sucrose-fed Otsuka Long-Evans Tokushima fatty rats: effect of an aldose reductase inhibitor, TATJ Nakamura, N Koh, F Sakakibara, et al.
Biochemical and Biophysical Research Communications|February 17, 2001
Role of PKC and TGF-beta receptor in glucose-induced proliferation of smooth muscle cellsY Yasuda, J Nakamura, Y Hamada, et al.
Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1997
Role of a sialyl Lewis(x)-like epitope selectively expressed on vascular endothelial cells in local skin inflammation of the ratT Akahori, Y Yuzawa, K Nishikawa, et al.
Diabetologia|March 1, 1985
Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated ratsN Hotta, H Kakuta, H Fukasawa, et al.
Clinical Chemistry|June 1, 1994
Enzyme immunoassay for erythrocyte aldose reductaseC Nishimura, Y Hamada, T Tachikawa, et al.
Diabetes Care|October 7, 2000
Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patientsY Hamada, J Nakamura, K Naruse, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 1, 1993
A placebo-controlled double-blind study of epalrestat (ONO-2235) in patients with diabetic neuropathyY Goto, N Hotta, Y Shigeta, et al.
Journal of the Autonomic Nervous System|August 29, 1998
Centrally administered TRH-induced insulin secretion is impaired in the Otsuka-Long-Evans-Tokushima Fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitusY Chen, K Uemura, S Yoshioka, et al.
Neuroendocrinology|August 1, 1997
NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, affects the central nervous system to produce peripheral hyperglycemia in conscious ratsK Uemura, T Tamagawa, Y Chen, et al.
Experimental Physiology|November 1, 1995
Effect of an aldose reductase inhibitor, SNK-860, on deficits in the electroretinogram of diabetic ratsN Hotta, N Koh, F Sakakibara, et al.
Life Sciences|January 1, 1997
Diabetic neuropathy in sucrose-fed Otsuka Long-Evans Tokushima fatty rats: effect of an aldose reductase inhibitor, TATJ Nakamura, N Koh, F Sakakibara, et al.
Biochemical and Biophysical Research Communications|February 17, 2001
Role of PKC and TGF-beta receptor in glucose-induced proliferation of smooth muscle cellsY Yasuda, J Nakamura, Y Hamada, et al.
Pageof 17